According to Vigeant, Moderna will create “a minimum of 200 permanent, full-time jobs available to qualified Marlborough residents” at this facility over a three-year period.

Source: https://www.communityadvocate.com/2023/04/25/moderna-wants-to-buy-marlborough-site/

Also on Monday, Pfizer rival Moderna reaffirmed its covid vaccine sales guidance for 2023 but said it was too early to accurately project where vaccination rates would land.

Source: https://www.irishexaminer.com/business/economy/arid-41251459.html

Argus lowered their price target on shares of Moderna from $160.00 to $140.00 and set a “buy” rating on the stock in a research note on Wednesday, September 13th.

Source: https://www.dailypolitical.com/2023/10/23/gulf-international-bank-uk-ltd-sells-9898-shares-of-moderna-inc-nasdaqmrna.html

Executives at GSK, Moderna, and CSL Seqirus that they are developing or are about to test sample human vaccines that better match the circulating subtype.

Source: https://www.dailymail.co.uk/health/article-11881691/Vaccine-makers-like-Moderna-say-theyre-standing-ready-human-bird-flu-pandemic.html?ns_mchannel=rss&ns_campaign=1490&ito=1490

Finally, Argus lowered their price objective on Moderna from $160.00 to $140.00 and set a “buy” rating for the company in a research note on Wednesday, September 13th.

Source: https://www.dailypolitical.com/2023/11/04/moderna-inc-nasdaqmrna-director-noubar-afeyan-sells-10000-shares.html

Finally, Banque Pictet & Cie SA raised its stake in Moderna by 1.9% in the 4th quarter.

Source: https://www.etfdailynews.com/2023/02/10/jpmorgan-chase-co-increases-moderna-nasdaqmrna-price-target-to-138-00/

I think this is a really interesting product for Moderna because it's not just one thing.

Source: https://seekingalpha.com/article/4655245-moderna-inc-mrna-presents-35th-annual-piper-sandler-healthcare-conference-transcript?source=feed_all_articles

It is notable that other vaccines that used the same technology without the pseudouridine were not as successful as the Pfizer-BioNTech and Moderna vaccines.

Source: https://www.forbes.com/sites/milletienne/2023/10/07/nobel-prize-goes-to-scientists-who-paved-the-way-for-covid-19-vaccine/

Moderna acknowledges that body-wide rashes are among the allergic reactions that can occur in rare cases following a vaccine dose, but says those symptoms typically present themselves within minutes of the shot.

Source: https://www.cbc.ca/news/canada/ottawa/covid-vaccine-moderna-side-effect-government-help-1.6294908?cmp=rss

Moderna and IBM scientists will apply MoLFormer, an AI foundation model that can help scientists predict a molecule's properties, and could help them understand the characteristics of potential mRNA medicines.

Source: https://vator.tv/news/2023-05-01-digital-health-news-funding-round-up-in-the-prior-week-may-1-2023

Moderna Chief Executive Officer Stephane Bancel told CNBC recently that the company is moving aggressively into Phase 3 studies with the belief that “anywhere Keytruda works, this should work.”

Source: https://rapidcityjournal.com/opinion/columnists/lisa-jarvis-cancer-vaccine-hunt-makes-progress-finally/article_dbc577e9-41c2-5490-9349-a77c6a27e369.html

Moderna has been working since 2019 with Merch (MRK) to develop mRNA-4157/V940, a personalized mRNA therapy.

Source: https://www.forbes.com/sites/jonmarkman/2023/05/10/modernas-revolutionary-cancer-vaccine-sets-investors-abuzz/

Moderna itself has some 40 different therapies in its pipeline, seven of them late stage.

Source: https://seekingalpha.com/article/4660078-when-multiple-megatrends-collide-lives-might-be-saved?source=feed_all_articles

Moderna may have completed extensive due diligence into Generation and its platform - the two companies are neighbors in Cambridge, Mass., after all - or it may simply be taking a calculated gamble.

Source: https://seekingalpha.com/article/4591546-moderna-generation-bio-collaboration-seismic-or-disastrous?source=feed_all_articles

Moderna reported a profit of $3.61 per shares for the fourth quarter, lower than the average of estimates of $4.68 per share.

Source: https://www.marketscreener.com/news/latest/Moderna-sticks-to-5-billion-sales-view-for-COVID-shot-despite-solid-Q4--43066126/?utm_medium=RSS&utm_content=20230223

Moderna shares are up in recent months, but a $173.25 closing price on Friday is more than 65% off their pandemic high of close to $500 in August 2021.

Source: https://gazette.com/news/us-world/drug-companies-face-covid-cliff-in-2023-as-sales-set-to-plummet/article_8a59d789-acc9-5db0-b5e5-ed2c8d18678c.html

Naturally, this sent Moderna’s stock soaring and made at least Moderna executives into billionaires.

Source: https://www.counterpunch.org/2023/03/31/making-the-rich-richer-the-silicon-valley-bank-bailout/

New Brunswick will continue to use the Moderna infant vaccines it has for children aged six month to four years until either the stock is depleted or the doses expire, said Hatchard.

Source: https://www.cbc.ca/news/canada/new-brunswick/moderna-infant-vaccine-new-brunswick-supply-disruption-canada-1.6760155?cmp=rss

People 12 years and older can receive a Pfizer vaccination, and those 18 years and older can receive Pfizer or Moderna.

Source: https://thekeystonenews.com/2023/10/26/fda-approves-new-covid-19-booster/

Pfizer and Moderna continue to make billions of dollars in sales of COVID vaccines, although they are producing fewer doses.

Source: https://www.courant.com/2023/09/14/pfizer-and-moderna-are-pushing-the-new-covid-booster-should-you-get-it-the-cdc-is-about-to-decide/